; and (B) publish such fee revenue and fees in the Federal Register. (6) Limit The total amount of fees assessed for a fiscal year under this section may not exceed the total costs for such fiscal year for the resources allocated for the process for the review of biosimilar biological product applications. . (d) Application fee waiver for small business Subsection (d)(1) of section 744H of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–52 ), as redesignated by subsection (c)(1), is amended— (1) by striking subparagraph (B); (2) by striking shall pay— and all that follows through application fees and inserting shall pay application fees ; and (3) by striking ; and at the end and inserting a period. (e) Effect of failure To pay fees Subsection (e) of section 744H of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–52 ), as redesignated by subsection (c)(1), is amended by striking all fees and inserting all such fees . (f) Crediting and availability of fees Subsection (f) of section 744H of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–52 ), as redesignated by subsection (c)(1), is amended— (1) in paragraph (2)— (A) by striking subparagraph (C) (relating to fee collection during first program year) and inserting the following: (C) Compliance The Secretary shall be considered to have met the requirements of subparagraph (B) in any fiscal year if the costs described in such subparagraph are not more than 15 percent below the level specified in such subparagraph. ; and (B) in subparagraph (D)— (i) in the heading, by striking in subsequent years ; and (ii) by striking (after fiscal year 2013) ; and (2) in paragraph (3), by striking 2013 through 2017 and inserting 2018 through 2022 . 404. Reauthorization; reporting requirements Section 744I of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 379j–53 ) is amended— (1) in subsection (a)— (A) by striking 2013 and inserting 2018 ; and (B) by striking Biosimilar User Fee Act of 2012 and inserting Biosimilar User Fee Amendments of 2017